CanSino Biologics Inc.

CASBFOTCHealthcare● Active

$3.97

+$0.97(+32.33%)

Market Cap$1.4B

P/E Ratio—

52W High$6.99

52W Low$3

Avg Volume49

Open$4.10

Beta1.16

Net Income Financials Revenue

CanSino Biologics Inc. (CASBF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

CASBF · net income · updated Jun 8, 2026

Core profitability metrics

CASBF · net income · margin · TTM · CAGR

Net income was $27.2M for FY2025 (fiscal year ending 2025-12-31), up 107.2% year-over-year. Net profit margin was 2.6%. Based on available data, CanSino Biologics Inc. has been profitable since at least 2021.

FY2025 Net Income$27.2M▲ +107.2% YoY

Trailing 12M (TTM)−$836,081trailing 4 quarters sum

Net Profit Margin2.6%$27.2M ÷ $1.03B

YoY Change+107.2%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2021

▸ FMP /income-statement · Annual · CASBF net income history · CASBF profit margin

Annual net income data

CASBF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$27.2M▲ +107.2%2.6%$1.03B

FY2024Loss−$378.9M▲ +74.4%-45.9%$824.9M

FY2023Loss−$1.48B▼ 63.0%-429.6%$345.2M

FY2022Loss−$909.4M▼ 147.5%-88.2%$1.03B

FY2021★ First Profit$1.91B▲ +582.7%44.5%$4.30B

Net income vs peers (Healthcare)

CASBF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

CanSino Biologics Inc.YOU

CASBF

$27.2M+107.2%2.6%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

CanSino Biologics Inc. (CASBF) reported net income of $27.2M for FY2025 (fiscal year ending 2025-12-31), up 107.2% year-over-year. The net profit margin was 2.6% — meaning the company kept $0.03 of every dollar of revenue as profit.

Based on available data, CanSino Biologics Inc. has been profitable since at least 2021. Net income reached a peak of $1.91B in FY2021. Data available for 10 fiscal years.

CanSino Biologics Inc.'s net profit margin was 2.6% for FY2025, based on the latest annual results.

Investors sometimes search for "CanSino Biologics Inc. net worth" — the company's market capitalization is a separate figure from CASBF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

CASBF net income · 5 questions

CanSino Biologics Inc. is profitable. The company reported net income of $27.2M for FY2025, a net profit margin of 2.6%. Net income was up 107.2% year-over-year. Based on available data, CanSino Biologics Inc. has been profitable since at least 2021.

is CASBF profitabledoes CASBF make a profitCASBF profitabilityCASBF profitable company

▸ Source: FMP /income-statement · GAAP · CanSino Biologics Inc. · CanSino Biologics Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026